Skip to main content

Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Announced Positive 12-month Follow-on Data for Iopofosine I 131 in relapsed/refractory Waldenström Macroglobulinemia (r/r WM)  Completed Financing of up to $140 Million to Support Initiation of Confirmatory Study of Iopofosine I 131 in r/r WM and Subsequent U.S. FDA Filing for Accelerated Approval Efficacy Results from r/r WM Patients in CLOVER-WaM Phase 2b Study Treated with Iopofosine I 131 Immediately Following BTK Inhibitor Therapy Selected for Presentation at ASCO 2026 Dosed First Patients in Phase 1b Dose Finding Study for CLR 125 in Triple Negative Breast Cancer with Early Dosimetry, Safety and Efficacy Data Expected Mid-year 2026 Company to Hold Webcast and Conference Call at 8:30 AM ET Today FLORHAM PARK, N.J., May 14, 2026 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical...

Continue reading

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Preconditioning-free (PC-free) 6-to-9-month clinical data with a single infusion of the lowest dose of rese-cel in the RESET-PV® study presented today at ASGCT 2026 Annual Meeting along with initial rese-cel translational data using Cellares’ industrialized, automated manufacturing PC-free rese-cel initial data from the lowest dose RESET-SLE™ cohort expected in 1H26 Pivotal RESET-Myositis® cohort with outpatient dosing option progressing to support first planned BLA submission for rese-cel next year Second pivotal indication for advancement to be announced after presentation of complete Phase 1/2 lupus and scleroderma data during June 2026 EULAR Congress PHILADELPHIA, May 14, 2026 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative...

Continue reading

Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights

Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 million Invivyd in vitro data showed continued neutralizing activity of pemivibart and VYD2311 against SARS-CoV-2 variant BA.3.2.2 (“Cicada”), confirming anticipated activity DECLARATION trial Independent Data Monitoring Committee (IDMC) ad hoc review of unblinded VYD2311 safety data resulted in IDMC recommendation for reduction of post-dose monitoring time from two hours to thirty minutes Operating expense increase quarter-over-quarter primarily attributable to DECLARATION pivotal program costs for VYD2311 for which top-line data is anticipated in Q3 2026 Strong balance sheet with Q1 2026 ending cash and cash equivalents of $184.2 million; additional ~$20 million in gross proceeds from usage...

Continue reading

Brookfield Wealth Solutions Announces First Quarter Results and Corporate Simplification

BROOKFIELD, NEWS, May 14, 2026 (GLOBE NEWSWIRE) — Brookfield Wealth Solutions (NYSE, TSX: BNT) today announced financial results for the three months ended March 31, 2026. Sachin Shah, CEO of Brookfield Wealth Solutions, stated, “We have built a scaled and well capitalized insurance platform with a resilient portfolio of $180 billion insurance assets today. Our established U.S. platform continues to expand its product and distribution capabilities, and we are now a leader in the U.K. pension market. We look forward to further growing our international operations over time, with a focus on generating high-quality earnings and durable risk-adjusted returns for our business.”UnauditedAs of and for the periods ended March 31(US$ millions, except per share amounts) Three Months Ended  2026       2025  Total assets $ 156,059     $ 141,612  Distributable...

Continue reading

LanzaTech Reports First Quarter 2026 Financial Results

Sustained Focus on Execution as Transformation Progresses SKOKIE, Ill., May 14, 2026 (GLOBE NEWSWIRE) — LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, today reported its financial and operating results for the first quarter ended March 31, 2026. Key Highlights:Successful Closing of Private Placement Financings: In January 2026, LanzaTech announced the closing of the sale and issuance of shares of its common stock to a group of investors, including new investor, SiteGround, for gross proceeds of $20.0 million and in May 2026, the Company entered into a subscription agreement with LanzaTech Global SPV, LLC, an entity controlled by a large existing investor, resulting in the immediate receipt of $10 million in gross proceeds through the issuance of 1,000,000 shares of...

Continue reading

Cheetah Net Supply Chain Service Inc. Announces First Quarter 2026 Results and Provides Corporate Update

IRVINE, Calif., May 14, 2026 (GLOBE NEWSWIRE) — Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq: CTNT), a logistics and warehousing services provider, today reported results for the quarter ended March 31, 2026 and provided a corporate update. For the quarter ended March 31, 2026, the Company reported revenue of $92,700 from its logistics and warehousing business, compared to $479,799 in the same period in 2025, representing a decrease of $387,099, or 80.7%. The Company recorded an operating loss of $764,319 for the quarter ended March 31, 2026, compared to an operating loss of $960,448 in the same period in 2025, representing a decrease of $196,129, or 20.4%. The decrease was primarily due to a decrease of $230,515 in selling, general and administrative expenses compared to the same period in 2025. The...

Continue reading

Montage Gold reports on its Q1-2026 activities

Koné project construction on-budget and ahead of schedule • Continued exploration success • Robust liquidity sources KONÉ CONSTRUCTION ACTIVITIESRapid progress achieved with +10.4 million hours worked to date, with +3,500 employees and contractors on-site Ahead of schedule with first gold pour targeted in late Q4-2026 through the oxide circuit and on budget with $636.9 million of capital committed as at today, representing approximately 72% of the total upfront capital expenditure Key process plant achievements include successful installation of all major mill components, erection of all reagent tanks, installation of agitation and gearboxes ongoing on CIL tanks, completion of the oxide sizer, and the rapid advancement of civil works on the hard-rock comminution circuit Other key infrastructure workstreams are also advancing ahead of...

Continue reading

Valeura Energy Inc.: First Quarter 2026 Results

SINGAPORE, May 14, 2026 (GLOBE NEWSWIRE) — Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) reports its unaudited financial and operating results for the three month period ended 31 March 2026. The complete quarterly reporting package for the Company, including the unaudited financial statements (the “Interim Financial Statement”) and associated management’s discussion and analysis (“MD&A”) are being filed on SEDAR+ at www.sedarplus.ca and posted the Company’s website at www.valeuraenergy.com. HighlightsOil production of 2.0 million bbls, averaging 22,326 bbls/d(1); Oil sales of 1.4 million bbls, resulting in an increase in crude oil inventory; Adjusted opex(2) of US$25.4/bbl, in line with the Company’s guidance expectations and operating costs of US$15.6/bbl(3); Adjusted cashflow from operations(2)...

Continue reading

Northland Power Reports First Quarter 2026 Results

TORONTO, May 13, 2026 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today reported financial results for the three months ended March 31, 2026. All dollar amounts set out herein are in Canadian dollars, unless otherwise stated. HighlightsDelivered Adjusted EBITDA and Free Cash Flow per share increased 18% and 17%, respectively, over the first quarter of 2025, driven by 31% higher wind production across European offshore wind assets. Advanced construction on the Baltic Power (1.1 GW) and Hai Long (1.0 GW) offshore wind projects including fabrication of the remaining major components and installation of over 50% of the turbines across the two projects. Secured a 30-year Corporate Power Purchase Agreement (CPPA) for the balance of the production of the Hai Long offshore wind Project.“We’ve...

Continue reading

Aptera Motors Reports First Quarter 2026 Financial Results

Reports Q1 2026 GAAP Net Loss of $10.2 Million Calculates Q1 2026 Adjusted Net Loss of $6.2 Million (Non-GAAP) Secured $17.1 Million in New Capital and Ended Quarter with $17.7 Million in Cash and Cash Equivalents Drove First Five Validation Vehicles Off the Low-Volume Validation Assembly Line in Carlsbad Grew Total Active Headcount Approximately 54% Year-over-Year to 57 Employees, Reflecting Continued Engineering Build-Out Resolved Zaptera Litigation, Dismissing All Claims with PrejudiceCARLSBAD, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Aptera Motors Corp. (NASDAQ: SEV) (“Aptera” or the “Company”), a solar mobility company advancing ultra-efficient transportation, today reported its financial results for the first quarter ended March 31, 2026. “The first quarter of 2026 reflected the disciplined execution and steady operational...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.